Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.

Chun-Ming HuangMing-Yii HuangCheng-Jen MaYung -Sung YehHsiang-Lin TsaiChing-Wen HuangChih-Jen HuangJaw-Yuan Wang

Published in: Radiation oncology (London, England) (2017)

Our results demonstrated that neoadjuvant chemoradiotherapy is feasible and safe. A prominent pCR rate with an acceptable toxicity profile suggests that the multimodality therapy might be a treatment option for patients with LACC.

Keyphrases

locally advanced
rectal cancer
neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
phase ii study
oxidative stress
stem cells
clinical trial
metastatic colorectal cancer
oxide nanoparticles